1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Sclerosis, Systemic: new trials by email Literature Review of Sclerosis, Systemic trials Research Report on Sclerosis, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis Placebo, tocilizumab [RoActemra/Actemra] - Sclerosis, Systemic | Phase 3 | Completed | Hoffmann-La Roche | 87 | 2012-03-01 | 2016-09-23 |
Connective Tissue Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
tocilizumab (1)
Canada (1) · France (1) · Germany (1) · United Kingdom (1) · United States (1)
PMID 27156934, PMID 29066464, PMID 29853453, PMID 29858547, PMID 33294861